The present invention relates to a controlled release sustained-release tablet having a pot life of at least 1 year and containing bupropion hydrochloride, hydroxypropyl methylcellulose and cysteine hydrochloride or glycine hydrochloride, which tablet effectively releases bupropion hydrochloride in the human body. It has a surface area: volume ratio to adjust.
展开▼